These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10639533)

  • 1. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom.
    Marshall RP; Puddicombe A; Cookson WO; Laurent GJ
    Thorax; 2000 Feb; 55(2):143-6. PubMed ID: 10639533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.
    Johnston ID; Prescott RJ; Chalmers JC; Rudd RM
    Thorax; 1997 Jan; 52(1):38-44. PubMed ID: 9039238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis.
    Hubbard R
    Eur Respir J Suppl; 2001 Sep; 32():119s-121s. PubMed ID: 11816818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial cryptogenic fibrosing alveolitis: a case report.
    Stinson JC; Tomkin GH
    Ir J Med Sci; 1992 Feb; 161(2):42-3. PubMed ID: 1517052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK general practice research database.
    Hubbard R; Venn A
    Thorax; 2000 Oct; 55(10):864-6. PubMed ID: 10992540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
    Hubbard R; Venn A; Lewis S; Britton J
    Am J Respir Crit Care Med; 2000 Jan; 161(1):5-8. PubMed ID: 10619790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis.
    Peckham RM; Shorr AF; Helman DL
    Respiration; 2004; 71(2):165-9. PubMed ID: 15031572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study.
    Hubbard R; Johnston I; Britton J
    Chest; 1998 Feb; 113(2):396-400. PubMed ID: 9498958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis.
    du Bois RM; Wells AU
    Eur Respir J Suppl; 2001 Sep; 32():43s-55s. PubMed ID: 11816824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans.
    Chan TY; Hansell DM; Rubens MB; du Bois RM; Wells AU
    Thorax; 1997 Mar; 52(3):265-70. PubMed ID: 9093344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm).
    Musk AW; Zilko PJ; Manners P; Kay PH; Kamboh MI
    Chest; 1986 Feb; 89(2):206-10. PubMed ID: 3484694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom.
    Johnston ID; Gomm SA; Kalra S; Woodcock AA; Evans CC; Hind CR
    Eur Respir J; 1993 Jun; 6(6):891-3. PubMed ID: 8339811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial idiopathic pulmonary fibrosis: clinical features and outcome.
    Lee HL; Ryu JH; Wittmer MH; Hartman TE; Lymp JF; Tazelaar HD; Limper AH
    Chest; 2005 Jun; 127(6):2034-41. PubMed ID: 15947317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia.
    Kolek V
    Acta Univ Palacki Olomuc Fac Med; 1994; 137():49-50. PubMed ID: 7778506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
    Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptogenic fibrosing alveolitis with preserved lung volumes.
    Doherty MJ; Pearson MG; O'Grady EA; Pellegrini V; Calverley PM
    Thorax; 1997 Nov; 52(11):998-1002. PubMed ID: 9487350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests.
    Dawson JK; Fewins HE; Desmond J; Lynch MP; Graham DR
    Thorax; 2001 Aug; 56(8):622-7. PubMed ID: 11462065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the aetiology of cryptogenic fibrosing alveolitis.
    Britton J; Hubbard R
    Histopathology; 2000 Nov; 37(5):387-92. PubMed ID: 11119119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rising mortality from cryptogenic fibrosing alveolitis.
    Johnston I; Britton J; Kinnear W; Logan R
    BMJ; 1990 Nov; 301(6759):1017-21. PubMed ID: 2249048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.